Progesterone

Generic Name
Progesterone
Brand Names
Bijuva, Crinone, Endometrin, Prochieve, Prometrium
Drug Type
Small Molecule
Chemical Formula
C21H30O2
CAS Number
57-83-0
Unique Ingredient Identifier
4G7DS2Q64Y
Background

Progesterone is a hormone that occurs naturally in females, and is essential for endometrial receptivity, embryo implantation, and the successful establishment of pregnancy. A low progesterone concentration or an insufficient response to progesterone can cause infertility and pregnancy loss . Progesterone is used in various contraceptive preparations to prevent ovulation and fertilization , as well as in other formulations to promote and support pregnancy. Please see Medroxyprogesterone acetate, Megestrol acetate, Dydrogesterone and Hydroxyprogesterone entries for information on various other forms of progesterone.

Pharmaceutical progesterone is made from a plant source as a starting material and is chemically identical to progesterone of human ovarian origin . Progesterone is available in gelatinized capsule form, vaginal gel form, tablet form, vaginal insert form, and injection form, all used for various purposes .

Indication

Gelatinized capsules

The gelatinized capsules are indicated for use in the prevention of endometrial hyperplasia in non-hysterectomized postmenopausal women who are receiving conjugated estrogens tablets. They are also indicated for use in secondary amenorrhea .

Vaginal gel

Progesterone gel (8%) is indicated as progesterone supplementation or replacement as part of an Assisted Reproductive Technology (“ART”) treatment for infertile women with progesterone deficiency. The lower concentration progesterone gel (4%) is used in the treatment of secondary amenorrhea, with the use of the 8% concentration if there is no therapeutic response to the 4% gel .

Vaginal insert

This form is indicated to support embryo implantation and early pregnancy by supplementation of corpus luteal function as part of an Assisted Reproductive Technology (ART) treatment program for infertile women .

Injection (intramuscular)

This drug is indicated in amenorrhea and abnormal uterine bleeding due to hormonal imbalance in the absence of organic pathology, such as submucous fibroids or uterine cancer .

Tablets, contraceptive

The tablet form of progesterone in contraceptive formulations is indicated for the prevention of pregnancy .

Associated Conditions
Abnormal Uterine Bleeding, Amenorrhea, Endometrial hyperplasia caused by conjugated estrogen, Moderate to Severe Vasomotor Symptoms, Pregnancy, Secondary Amenorrhea, Recurrent spontaneous preterm birth
Associated Therapies
Assisted Reproductive Technology therapy

Progesterone Supplementation for HIV-positive Pregnant Women on Anti-Retrovirals

Phase 2
Conditions
Interventions
First Posted Date
2015-03-26
Last Posted Date
2015-07-30
Lead Sponsor
Mount Sinai Hospital, Canada
Target Recruit Count
40
Registration Number
NCT02400021
Locations
🇨🇦

Mount Sinai Hospital, Toronto, Ontario, Canada

🇨🇦

St. Michael's Hospital, Toronto, Ontario, Canada

🇨🇦

Maple Leaf Medical Clinic, Toronto, Ontario, Canada

and more 2 locations

Lactoferrin or Progesterone for Prevention of Preterm Delivery

First Posted Date
2015-02-26
Last Posted Date
2018-05-08
Lead Sponsor
University of Padova
Target Recruit Count
1030
Registration Number
NCT02372942
Locations
🇮🇹

University of Padua, Padua, Italy

Vaginal Progesterone for Prevention of Preterm Labor in Asymptomatic Twin Pregnancies With Sonographic Short Cervix

Phase 4
Completed
Conditions
Interventions
First Posted Date
2015-01-14
Last Posted Date
2015-01-15
Lead Sponsor
Mohamed Sayed Abdelhafez
Target Recruit Count
182
Registration Number
NCT02338830
Locations
🇪🇬

Obstetrics and Gynecology Department in Mansoura University Hospital, Mansoura, Dakahlia, Egypt

🇪🇬

Private practice settings, Mansoura, Dakahlia, Egypt

Comparing Double Dose of Vaginal Progesterone to no Treatment for Prevention of Preterm Birth in Twins and Short Cervix

Not Applicable
Terminated
Conditions
Interventions
First Posted Date
2014-12-31
Last Posted Date
2017-08-21
Lead Sponsor
HaEmek Medical Center, Israel
Target Recruit Count
15
Registration Number
NCT02329535
Locations
🇮🇱

Haemek Medical Center, Afula, Israel

🇮🇱

The Nazareth hospital, Nazareth, Israel

Perimenopausal Effects of Estradiol on Reward Responsiveness

Phase 4
Completed
Conditions
Interventions
First Posted Date
2014-10-02
Last Posted Date
2019-11-12
Lead Sponsor
University of North Carolina, Chapel Hill
Target Recruit Count
64
Registration Number
NCT02255175
Locations
🇺🇸

University of North Carolina, Chapel Hill, North Carolina, United States

Progesterone Effect on Individuals Diagnoses With AD and PTSD.

First Posted Date
2014-07-10
Last Posted Date
2023-04-26
Lead Sponsor
Yale University
Target Recruit Count
13
Registration Number
NCT02187224
Locations
🇺🇸

VA Connecticut Healtcase System, West Haven, Connecticut, United States

Progesterone for the Prevention of Miscarriage and Preterm Birth in Women With First Trimester Bleeding: PREEMPT Trial

Phase 2
Completed
Conditions
Interventions
First Posted Date
2014-05-23
Last Posted Date
2021-08-23
Lead Sponsor
Sir Mortimer B. Davis - Jewish General Hospital
Target Recruit Count
850
Registration Number
NCT02145767
Locations
🇨🇦

St. Mary's Hospital, Montreal, Quebec, Canada

🇨🇦

CHU Sainte-Justine, Montreal, Quebec, Canada

🇨🇦

MUHC Royal Victoria Hospital, Montreal, Quebec, Canada

and more 4 locations

Randomized Trial of Maternal Progesterone Therapy

First Posted Date
2014-05-08
Last Posted Date
2023-08-09
Lead Sponsor
Children's Hospital of Philadelphia
Target Recruit Count
102
Registration Number
NCT02133573
Locations
🇺🇸

The Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, United States

The Effect of Different Types of Progestin on Sleeping of Menopausal Women

First Posted Date
2014-03-13
Last Posted Date
2017-05-31
Lead Sponsor
Chiang Mai University
Target Recruit Count
100
Registration Number
NCT02086032
Locations
🇹🇭

Obstetrics and Gynecology department, Faculty of Medicine, Chiang Mai University, Muang, Chiang Mai, Thailand

© Copyright 2024. All Rights Reserved by MedPath